These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1898192)

  • 1. [Beta-lactamase distribution among pathogenic microorganisms. The antibacterial action of a combined preparation of ampicillin/sulbactam (Unasyn)].
    Akar ZhF
    Antibiot Khimioter; 1991 Jun; 36(6):5-8. PubMed ID: 1898192
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV; Botta GA; Pesce A; Schito GC
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of the combined preparation ampicillin/sulbactam (Unasyn) in the therapy of puerperal endometritis].
    Nikonov AP; Ankirskaia AS
    Antibiot Khimioter; 1991 Jun; 36(6):25-7. PubMed ID: 1898185
    [No Abstract]   [Full Text] [Related]  

  • 5. [The combined preparation ampicillin/sulbactam (Unasyn) in the general surgical clinic].
    Bogomolova NS; Bronskaia LK
    Antibiot Khimioter; 1991 Jun; 36(6):15-8. PubMed ID: 1898182
    [No Abstract]   [Full Text] [Related]  

  • 6. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
    Chao HP; Ho SW; Luh KT; Hsieh WC
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1992; 72(291):137-42. PubMed ID: 1287401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of ampicillin/sulbactam (Unasyn) in treating inflammatory urological diseases].
    Perepanova TS; Kotliarova GA; Kondrat'eva EM; Siniukhin VN; Derevianko II; Safin RN
    Antibiot Khimioter; 1991 Jun; 36(6):21-5. PubMed ID: 1898184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
    Jones RN
    Drugs; 1988; 35 Suppl 7():17-26. PubMed ID: 3265377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli resistant to ampicillin/sulbactam.
    Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
    Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
    Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial activity of sultamicillin against clinical isolates from upper respiratory tract infections II].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Dec; 41(12):2065-74. PubMed ID: 3266883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
    Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC
    Microbios; 1993; 76(309):251-61. PubMed ID: 8302203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibitor effect of the ampicillin-sulbactam combination on Enterobacteriaceae resistant to ampicillin].
    Poiată A; Diculencu D; Buiuc D
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(1-2):67-9. PubMed ID: 1472781
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the resistance induction in enteric flora in children caused by oral ampicillin plus sulbactam.
    Soylu A; Sanlidag T; Türkmen M; Cakir N; Kavukçu S
    J Antimicrob Chemother; 1997 Jun; 39(6):833-5. PubMed ID: 9222058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.